Michael Silverman

4.1k citations
78 papers · 3.1k · 2 hit papers · h-index 25

Impact in

    • Sepsis Diagnosis and Treatment
    • Infective Endocarditis Diagnosis and Management
    • HIV, Drug Use, Sexual Risk
    • HIV/AIDS Research and Interventions
    • Clostridium difficile and Clostridium perfringens research

Papers in

    • HIV/AIDS Research and Interventions 10
    • Clostridium difficile and Clostridium perfringens research 4
    • Infective Endocarditis Diagnosis and Management 12
    • HIV, Drug Use, Sexual Risk 4

Michael Silverman

74 papers receiving 2.9k citations

Michael Silverman's Hit Papers

Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial 2023 · 390 citations
3900+7+14Years since publication200400600

Peers

Michael Silverman
Comparison fields: 5 of 129
  • Epidemiology 1k
  • Infectious Diseases 509
  • Applied Microbiology and Biotechnology 36
  • Virology 66
  • Molecular Biology 757
Replace Jérôme LeGoff with:
Jérôme LeGoff France
Olivier Épaulard France
Francisco Pozo Spain
Johannes G. Liese Germany
George M. Varghese India
Nicolás Dauby Belgium
Katy Fidler United Kingdom
Pritish K. Tosh United States
Gerdien A. Tramper‐Stranders Netherlands
Merete Storgaard Denmark
Michael Silverman relative to Jérôme LeGoff France Jérôme LeGoff's profile →
Citations per field
00.5×2×3.1×
Jérôme LeGoff · 1×
Citations per year

Countries citing papers authored by Michael Silverman

Since Specialization
Citations

This map shows the geographic impact of Michael Silverman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Silverman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Silverman more than expected).

Fields of papers citing papers by Michael Silverman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Silverman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Silverman. The network helps show where Michael Silverman may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael Silverman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Silverman Line = papers co-authored together Michael Silverman links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 78 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: Effect on survival in patients with septic shock*
Hit paper breakdown →
2004700
2
Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial
Hit paper breakdown →
2023390
3 2020291
4 2010156
5 2008139
6 2009134
7 2018114
8 202197
9 202265
10 201363
11 201751
12 201949
13 202041
14 201940
15 201536
16 201736
17 201936
18 202033
19 201929
20 202029

About Michael Silverman

Michael Silverman is a scholar working on Infectious Diseases, Epidemiology, Modeling and Simulation, Applied Microbiology and Biotechnology and Virology, having authored 78 papers that have together received 3.1k indexed citations. Recurring topics across this work include Infective Endocarditis Diagnosis and Management (12 papers), HIV/AIDS Research and Interventions (10 papers), Gut microbiota and health (8 papers), HIV, Drug Use, Sexual Risk (4 papers), Clostridium difficile and Clostridium perfringens research (4 papers), COVID-19 epidemiological studies (4 papers), Cancer Immunotherapy and Biomarkers (3 papers) and HIV Research and Treatment (3 papers). The work is most often cited by research in Epidemiology (1k citations), Infectious Diseases (509 citations), Applied Microbiology and Biotechnology (36 citations), Virology (66 citations) and Molecular Biology (757 citations). Michael Silverman has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Ian R. Davis, Dylan R. Pillai, Sharon L. Koivu, Jose Angel Lorente, Jay S. Steingrub, Steven H. Grossman, Laurent Holzapfel, Angela McLuckie, Jan Bakker and Michael Brockway. Their work appears in journals such as JAMA Network Open, PLoS ONE, The Journal of Infectious Diseases, Open Forum Infectious Diseases and Clinical Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact